Junshi Biosciences Announces Lancet Infectious Diseases Publication of Results from the 2nd Phase 3 Study of VV116 for Treating COVID-19

SHANGHAI, China, Nov. 22, 2023 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced a new publication in the Lancet Infectious Diseases. The paper presents final analysis results from a multicenter, double-blind, phase 3, […]

Read More

?? Morning digest November 23

The following is a list of selected news summaries reported last weekend by the Vietnam News Agency.

– Party General Secretary Nguyen Phu Trong chaired a meeting of the standing board of the Central Steering Committee on Prevention and Control of Co…

Read More